Childhood Acute Leukemia — Trials

Childhood Acute Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

462 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 77
Recruiting: 50
Ph III recruiting: 2
Growth YoY: −47.6%
Industry share: 6%
Top sponsor: Nationwide Children's Hospital
Termination share: 19.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (40)

clinicaltrialsPublishedShowing 451–462 of 462 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00093821	Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors	completed	Phase 1	70	National Cancer Institute (NCI)NIH	1	Jun 4, 2013	clinicaltrials
NCT00005811	Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment	completed	Phase 2	77	National Cancer Institute (NCI)NIH	1	Feb 21, 2013	clinicaltrials